Back to search

Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo

Data up to Jan 2025

Published1991
Citations3,106
References29

Total Citations Per Year

Abstract

References (29)

Nonparametric Estimation from Incomplete Observations

1958 • 7,673 citations

Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial Infarction

1989 • 3,227 citations

The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction.

1984 • 1,306 citations

Ventricular Premature Beats and Mortality after Myocardial Infarction

1977 • 659 citations

Risk factors for sudden death after acute myocardial infarction: Two-year follow-up

1984 • 548 citations

Ventricular ectopic beats and their relation to sudden and nonsudden cardiac death after myocardial infarction.

1979 • 466 citations

Flecainide: Its proarrhythmic effect and expected changes on the surface electrocardiogram

1984 • 279 citations

Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: The CAPS

1988 • 233 citations

Malignant ventricular tachyarrhythmias associated with the use of encainide

1981 • 215 citations

Effect of antiarrhythmic drugs on mortality after myocardial infarction

1983 • 202 citations

International mexiletine and placebo antiarrhythmic coronary trial: I. Report on arrhythmia and other findings

1984 • 186 citations

ORAL MEXILETINE IN HIGH-RISK PATIENTS AFTER MYOCARDIAL INFARCTION

1980 • 176 citations

Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainide

1986 • 153 citations

Risk factors for the development of proarrhythmic events

1987 • 131 citations

The cardiac arrhythmia pilot study

1986 • 130 citations

Prophylaxis of ventricular tachyarrhythmias with intravenous and oral tocainide in patients with and recovering from acute myocardial infarction

1980 • 105 citations

Effects of encainide and its metabolites on energy requirements for defibrillation.

1986 • 92 citations

A prospective randomized trial of tocainide in patients following myocardial infarction

1980 • 87 citations

Effect on survival after myocardial infarction of long-term treatment with phenytoin.

1978 • 77 citations

Prophylactic antiarrhythmic therapy of high-risk survivors of myocardial infarction: lower mortality at 1 month but not at 1 year.

1987 • 69 citations

Treatment of ventricular arrhythmias by United States cardiologists: a survey before the cardiac arrhythmia suppression trial results were available

1990 • 53 citations

Effectiveness of amiodarone on ventricular arrhythmias during and after acute myocardial infarction

1987 • 50 citations

Flecainide: Electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia

1985 • 50 citations

Drug‐Device Interactions: Clinical Considerations

1985 • 48 citations

Safety of encainide for the treatment of ventricular arrhythmias

1986 • 47 citations

Proarrhythmic responses during electrophysiologic testing

1987 • 38 citations

Congestive heart failure after acute myocardial infarction in patients receiving antiarrhythmic agents for ventricular premature complexes (Cardiac Arrhythmia Pilot Study)

1989 • 34 citations

Treatment of life-threatening ventricular tachycardia with encainide hydrochloride in patients with left ventricular dysfunction

1988 • 28 citations

Pharmacologic causes of arrhythmogenic actions of antiarrhythmic drugs

1987 • 24 citations

Cited By (0)

No citing papers found in database

Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo (1991) – New England Journal of Medicine | Metascience Observatory Explorer